stockrowPrestige Consumer Healthcare Inc.
PBH Healthcare Drug Manufacturers Specialty & Generic
Prestige Consumer Healthcare Inc.’s revenue for fiscal 2026 (year ended March 2026) was $1.1 billion, down 4.31% from fiscal 2025.
- Revenue
- +22.7%
- EPS
- −38.4%
- Free cash flow
- −38.2%
- Total debt
- +100.9%
Quarter to September 2026, against a year earlier
Follow PBH
Alert me
Prestige Consumer Healthcare Inc. (PBH) EBITDA
Prestige Consumer Healthcare Inc.'s EBITDA for fiscal 2026 was $342.5M, down 7.11% from $368.7M in fiscal 2025. Over the twelve months to 30 September 2026 it was $330.9M. Over the past ten years it has ranged from $14.6M (fiscal 2023) to $378.3M (fiscal 2024); the current reading is higher than 75% of that period. Prestige Consumer Healthcare Inc. ranks 14th of 80 Drug Manufacturers Specialty & Generic companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2026 | $342.5M | (7.11%) |
| FY2025 | $368.7M | (2.55%) |
| FY2024 | $378.3M | 2,496.02% |
| FY2023 | $14.6M | (96.02%) |
| FY2022 | $366.2M | 10.13% |
| FY2021 | $332.5M | 2.65% |
| FY2020 | $324.0M | 207.93% |
| FY2019 | $105.2M | (58.85%) |
| FY2018 | $255.6M | 6.49% |
| FY2017 | $240.1M | (18.06%) |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Sep 2026 | $94.3M | 52.77% |
| Jun 2026 | $61.7M | (26.76%) |
| Mar 2026 | $84.3M | (6.89%) |
| Dec 2025 | $90.5M | 3.14% |
| 43 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| PBH Prestige Consumer Healthcare Inc. | $330.9M |
| XERS Xeris Biopharma Holdings, Inc. compare | $52.9M |
| RGC Regencell Bioscience Holdings Limited compare | −$12.5M |
| ALVO Alvotech compare | −$84.5M |
| TRLV Trulieve Cannabis Corp. compare | −$104.9M |
| AMLX Amylyx Pharmaceuticals, Inc. compare | −$165.9M |
| BCRX BioCryst Pharmaceuticals, Inc. compare | −$313.5M |
| PRGO Perrigo Company plc compare | −$1.2B |
| HCM HUTCHMED (China) Limited Sponsored ADR compare | −$3.3B |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on PBH
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement